143 related articles for article (PubMed ID: 11754163)
1. Re-evaluation of HBsAg detection kits approved for marketing in Japan.
Committee for Evaluation of In Vitro Diagnostic Devices, National Institute of Infectious Diseases.
Jpn J Infect Dis; 2001 Oct; 54(5):201-7. PubMed ID: 11754163
[No Abstract] [Full Text] [Related]
2. Evaluation of an indigenously manufactured rapid immunochromatographic test for detection of HBsAg.
Raj AA; Subramaniam T; Raghuraman S; Abraham P
Indian J Pathol Microbiol; 2001 Oct; 44(4):413-4. PubMed ID: 12035352
[TBL] [Abstract][Full Text] [Related]
3. Reactivity of genotypically distinct hepatitis B virus surface antigens in 10 commercial diagnostic kits available in Japan.
Mizuochi T; Okada Y; Umemori K; Mizusawa S; Sato S; Yamaguchi K
Jpn J Infect Dis; 2005 Apr; 58(2):83-7. PubMed ID: 15858285
[TBL] [Abstract][Full Text] [Related]
4. Single amino acid substitution in the hepatitis B virus surface antigen (HBsAg) "a" determinant affects the detection sensitivity of an HBsAg diagnostic kit.
Mizuochi T; Mizusawa S; Nojima K; Okada Y; Yamaguchi K
Clin Chim Acta; 2010 Apr; 411(7-8):605-6. PubMed ID: 20064501
[No Abstract] [Full Text] [Related]
5. [Preparation of the national reference panel for hepatitis B surface antigen].
Wu X; Zhou C; Gu WJ; Li HM; Qi ZB
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Aug; 22(4):311-3. PubMed ID: 19105354
[TBL] [Abstract][Full Text] [Related]
6. [Development of Highly Sensitive Quantitative HBsAg Reagent and Its Availability].
Moriyama K; Isomura M
Rinsho Byori; 2015 Jan; 63(1):44-52. PubMed ID: 26524878
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of sensitivity for wild type and mutant forms of hepatitis B surface antigen by four commercial HBsAg assays.
Moerman B; Moons V; Sommer H; Schmitt Y; Stetter M
Clin Lab; 2004; 50(3-4):159-62. PubMed ID: 15074469
[TBL] [Abstract][Full Text] [Related]
8. The analytic sensitivity and mutant detection capability of six hepatitis B surface antigen assays.
La'ulu SL; Roberts WL
Am J Clin Pathol; 2006 May; 125(5):748-51. PubMed ID: 16707377
[TBL] [Abstract][Full Text] [Related]
9. Reliability of rapid testing for hepatitis B in a region of high HIV endemicity.
Davies J; van Oosterhout JJ; Nyirenda M; Bowden J; Moore E; Hart IJ; Zijlstra EE; Chaponda M; Faragher B; Beeching NJ; Beadsworth MB
Trans R Soc Trop Med Hyg; 2010 Feb; 104(2):162-4. PubMed ID: 19931107
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis B surface antigen escape mutant in a first time blood donor potentially missed by a routine screening assay.
Levicnik-Stezinar S
Clin Lab; 2004; 50(1-2):49-51. PubMed ID: 15000220
[TBL] [Abstract][Full Text] [Related]
11. Deficiencies in the standardization and sensitivity of diagnostic tests for hepatitis B virus.
Gerlich WH; Glebe D; Schüttler CG
J Viral Hepat; 2007 Nov; 14 Suppl 1():16-21. PubMed ID: 17958638
[TBL] [Abstract][Full Text] [Related]
12. [Sensitivity and specificity of 4 domestic ELISA kits for detection of hepatitis B virus markers].
Wu X; Zhou C; Huang WJ; Qi ZB; Liang ZL; Li HM; Zhuang H
Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Sep; 29(9):915-8. PubMed ID: 19173858
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of 10 commercial diagnostic kits for in vitro expressed hepatitis B virus (HBV) surface antigens encoded by HBV of genotypes A to H.
Mizuochi T; Okada Y; Umemori K; Mizusawa S; Yamaguchi K
J Virol Methods; 2006 Sep; 136(1-2):254-6. PubMed ID: 16707169
[TBL] [Abstract][Full Text] [Related]
14. HBsAg diagnostic kits in the detection of hepatitis B virus mutation within "a" determinant.
Louisirirotchanakul S; Kanoksinsombat C; O'Charoen R; Fongsatikul L; Puapairoj C; Lulitanond V; Appassakij H; Promwong C; Wasi C
Viral Immunol; 2006; 19(1):108-14. PubMed ID: 16553556
[TBL] [Abstract][Full Text] [Related]
15. [Evaluations of 5 kinds of China-made enzyme immunoassay kits for hepatitis B virus surface antigen detection].
Zhang Y; Wang F; Ma JC
Zhongguo Yi Miao He Mian Yi; 2009 Oct; 15(5):388-91. PubMed ID: 20084960
[TBL] [Abstract][Full Text] [Related]
16. [Evaluation and application of a newly developed highly sensitive HBsAg chemiluminescent enzyme immunoassay for chronic hepatitis B patients].
Shinkai N; Tanaka Y; Matsuura K; Kani S; Naganuma H; Mizokami M
Rinsho Byori; 2010 Nov; 58(11):1078-84. PubMed ID: 21229705
[TBL] [Abstract][Full Text] [Related]
17. Lack of correlation between HBsAg and HBV DNA levels in blood donors who test positive for HBsAg and anti-HBc: implications for future HBV screening policy.
Kuhns MC; Kleinman SH; McNamara AL; Rawal B; Glynn S; Busch MP;
Transfusion; 2004 Sep; 44(9):1332-9. PubMed ID: 15318857
[TBL] [Abstract][Full Text] [Related]
18. Re-evaluation of HCV Ab detection kits approved for marketing in Japan.
Committee for Evaluation of In Vitro Diagnostic Devices
Jpn J Infect Dis; 2002 Feb; 55(1):33-6. PubMed ID: 11971162
[No Abstract] [Full Text] [Related]
19. [An evaluation of the sensitivity of commercial ELISA kits for the detection of HBsAg].
Babeş VT; Badea D; Picior M
Rev Roum Virol; 1991; 42(3-4):135-9. PubMed ID: 1814430
[TBL] [Abstract][Full Text] [Related]
20. Real-time PCR quantitation of hepatitis B virus total DNA and covalently closed circular DNA in peripheral blood mononuclear cells from hepatitis B virus-infected patients.
Mazet-Wagner AA; Baclet MC; Loustaud-Ratti V; Denis F; Alain S
J Virol Methods; 2006 Dec; 138(1-2):70-9. PubMed ID: 16962180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
